phosphatidylcholines has been researched along with nitroblue tetrazolium in 1 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (nitroblue tetrazolium) | Trials (nitroblue tetrazolium) | Recent Studies (post-2010) (nitroblue tetrazolium) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 2,315 | 17 | 92 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albright, CD; Craciunescu, CN; Salganik, RI; Vrablic, AS; Zeisel, SH | 1 |
1 other study(ies) available for phosphatidylcholines and nitroblue tetrazolium
| Article | Year |
|---|---|
Altered mitochondrial function and overgeneration of reactive oxygen species precede the induction of apoptosis by 1-O-octadecyl-2-methyl-rac-glycero-3-phosphocholine in p53-defective hepatocytes.
Topics: Animals; Antigens, Polyomavirus Transforming; Antioxidants; Apoptosis; Cell Line, Transformed; Electrophoresis, Agar Gel; Hepatocytes; Intracellular Membranes; Male; Membrane Potentials; Mitochondria, Liver; Nitroblue Tetrazolium; Phosphatidylcholines; Phospholipid Ethers; Rats; Rats, Inbred F344; Reactive Oxygen Species; Tumor Suppressor Protein p53; Vitamin E | 2001 |